Managers / Q3 2024 · view latest →
USA FINANCIAL FORMULAS
CIK 0001633716 · 6020 EAST FULTON STREET, ADA, MI, 49301 · 888-407-8198
Summary
USA Financial Formulas reported $643M in U.S.-listed holdings across 256 positions for Q3 2024.
Its largest position, Ishares Msci Eafe Etf, represents 12.7% of the portfolio.
Compared with Q2 2024, the fund opened 80 new positions and exited 121.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- ETP · 81.9% · $527M
- Common Stock · 16.4% · $105M
- Other · 1.0% · $6M
- REIT · 0.6% · $4M
- ADR · 0.2% · $1M
Quarter-over-Quarter Changes full breakdown →
vs Q2 2024 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| AVGOBroadcom Inc | NEW | +16.9K | 16.9K | +$3M | $3M |
| PANWPalo Alto Networks Inc | NEW | +3.9K | 3.9K | +$1M | $1M |
| EAElectronic Arts, Inc. | NEW | +9.4K | 9.4K | +$1M | $1M |
| KOCoca-Cola Co | NEW | +18.7K | 18.7K | +$1M | $1M |
| VRSKVerisk Analytics Inc | NEW | +5.0K | 5.0K | +$1M | $1M |
| AMGNAMGEN Inc. | NEW | +4.1K | 4.1K | +$1M | $1M |
| AZNNAstrazeneca plc - ADR | NEW | +16.6K | 16.6K | +$1M | $1M |
| GLWCorning, Inc. | NEW | +27.8K | 27.8K | +$1M | $1M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q3 2024
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $531M | 437 | Apr 14, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $550M | 414 | Jan 14, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $568M | 257 | Oct 10, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $586M | 240 | Jul 18, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $606M | 274 | Apr 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $636M | 286 | Jan 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $643M | 256 | Oct 8, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $617M | 297 | Jul 12, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $617M | 300 | Apr 30, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $572M | 333 | Feb 7, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $67M | 494 | Nov 27, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $63M | 372 | Oct 24, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $93M | 397 | Aug 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $117M | 410 | Feb 10, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $112M | 425 | Nov 8, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $119M | 395 | Jul 29, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $123M | 359 | May 6, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $127M | 338 | Jan 29, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $133M | 343 | Oct 9, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $135M | 257 | Aug 11, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $157M | 239 | Apr 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $241M | 251 | Feb 7, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $258M | 234 | Nov 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $199M | 120 | Aug 12, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $159M | 120 | May 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $402M | 327 | Feb 14, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.